Therapy and diagnostic tests used for Helicobacter pylori infection in the Scandinavian countries in 1998

Scandinavian Journal of Gastroenterology

Volumn 34, Issue 9, 1999, Pages 849-855

  Olafsson, S ^a   Berstad, A ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Antimicrobials; Follow up; Helicobacter pylori; Indications; Survey; Therapy

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; CLARITHROMYCIN; METRONIDAZOLE; PROTON PUMP INHIBITOR;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; DIAGNOSTIC TEST; DYSPEPSIA; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; TREATMENT INDICATION;

ANTACIDS; ANTI-BACTERIAL AGENTS; BISMUTH; BREATH TESTS; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; GASTROINTESTINAL DISEASES; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PROTON PUMPS; SCANDINAVIA; SEROLOGIC TESTS;

EID: 0032886016     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655299750025291     Document Type: Article

References (31)

1. van der Hulst RW, Keller JJ, Rauws EA, Tytgat GN. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1996;1:6-19.
2. Christensen AH, Logan RP, Noach LA, Gjorup T. Do clinicians accept the role of Helicobacter pylori in duodenal ulcer disease: a survey of European gastroenterologists and general practitioners. J Intern Med 1994;236:501-5.
3. Babbs C. H. pylori-associated gastroduodenal disease: survey of British physicians' views. Gut 1995;37 Suppl 1:347.
4. Boekema PJ, Veenendaal RA, van Berge-Henegouwen GP. After a decade of Helicobacter pylori in The Netherlands. A survey of the practice of the members of the Dutch Society of Gastroenterology. Neth J Med 1997;51:129-33.
5. Fendrick AM, Hirth RA, Chernew ME, Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease. Am J Gastroenterol 1996;91: 1544-8.
6. Breuer T, Goodman KJ, Malaty HM, Sudhop T, Graham DY. How do clinicians practicing in the U.S. manage Helicobacter pylori-related gastrointestinal diseases'? A comparison of primary care and specialist physicians. Am J Gastroenterol 1998;93:553-61.
7. Breuer T, Sudhop T, Goodman KJ, Graham DY, Malfertheiner P. How do practicing clinicians manage Helicobacter pylori-related gastrointestinal diseases in Germany? A survey of gastroenterologists and family practitioners. Helicobacter 1998; 3:1-8.
8. Norsk oppdateringskonferanse om behandling av Helicobacter pylori ved ulcus pepticum. |A Norwegian conference on updating of the treatment of Helicobacter pylori in peptic ulcer. Interessegruppe for Gastroenterologi.| Tidsskr Nor Laegeforen 1994;114:2495-7.
9. Läkemedelsverket: Behandling av Helicobacter pylori-infektioner, rekommendationer. Inform Lakemedelsverket 1996;7:65-9.
10. Farkilla M, Julkunen R, Niemala S, Nuutinen H. Kosunen T, Karvonen A, et al. Helicobacter pylori-infektion dignostiikusta, hoidosta ja seurannasta. Suom Laakaril 1996;51:9-13.
11. Mulfertheiner P. Megraud F, O'Morain C, Bell D, Bianchi Porro G, Deltenre M, et al. Current European concepts in the management of Helicobacter pylori infection-the Maastricht Consensus Report. The European Helicobacter pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol 1997;9:1-2.
12. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994;272:65-9.
13. Rabenek L, Graham D. Helicobacter pylori: when to test, when to treat [editorial]. Ann Intern Med 1997;126:315-6.
14. Buckley M, O'Morain C. Helicobacter pylori eradication- a surrogate marker for duodenal ulcer healing [comment]. Eur J Gastroenterol Hepatol 1996;8:415-6.
15. Michlke S, Bayerdorffer E, Lehn N, Mannes GA, Hochter W, Weingart J, et al. Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995;7:975-8.
16. Labenz J, Tillenburg B, Peitz U, Borsch G. Long-term consequences of Helicobacter pylori eradication: clinical aspects. Scand J Gastroenterol 1996;31 Suppl 215:111-5.
17. Berstad A, Hatlebakk JG, Wilhelmsen I, Berstad K, Bang CJ, Nysaeter G, et al. Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infection. Hepatogastroenterology 1995;42:655-9.
18. Zanten SJOVv, Talley NJ. Should antibiotic treatment of Helicobacter-positive patients with non-ulcer dyspepsia now be recommended? Eur J Gastroenterol Hepatol 1998;10:367-70.
19. O'Connor HJ, Cunnane K. Helicobacter pylori and gastrooesophageul reflux disease- a prospective study. Ir J Med Sci 1994;163:369-73.
20. Lee J, Breslin N, O'Morain C. Is there an association between Helicobacter pylori infection and reflux oesophagitis? Tr J Med Sci 1996; 165 Suppl 4:A10.
21. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
22. Kuipers EJ, Lundell L, Klinkenherg-Knol EC, Havu N, Festen HP, Leidman B, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication [see comments]. N Engl J Med 1996;334:1018-22.
23. Berstad AE, Hatlebakk JG, Maartmann-Moe H, Berstad A, Brandtzaeg P. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. Gut 1997;41:740-7.
24. FDA Omeprazole description, no 791092728, issued June 1998. Federal and Drug Administration's database on the Internet (http://www.fda.gov); 1998.
25. Labenz J, Gyenes E, Ruhl GH, Borsch G. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study [see comments]. Gut 1993:34:1167-70.
26. Graham KS, Malaty H, el-Zimaity HM, Genta RM, Cole RA, al-Assi MT, et al. Variability with omeprazole-amoxieillin combinations for treatment of Helicobacter pylori infection. Am J Gastroenterol 1995;90:1415-8.
27. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromyein resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance [see comments]. N Engl J Med 1997;337: 441-6.
28. Lerang F, Moum B, Hang JB, Berge T, Tolås P, Sandvei PK, et al. Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy. Scand J Gastroenterol 1997;32:1209-14.
29. van der Hulst RW, van der Ende A, Homan A, Roorda P, Dankert J, Tytgat GN. Influence of metroniduzole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication. Gut 1998:42:166-9.
30. Lerang F, Hang JB, Moum B, Mowinckel P, Berge T, Ragnhildstveit E, et al. Accuracy of IgG serology and other tests in confirming Helicobacter pylori eradication. Scand J Gastroenterol 1998:33:710-5.
31. 2-receptor antagonists on test results. Scand J Gastroenterol 1998;33: 364-9.